Cingulate, Inc. (CING)
4.26
+0.02
(+0.47%)
USD |
NASDAQ |
Nov 06, 16:00
4.25
-0.01
(-0.23%)
After-Hours: 20:00
Cingulate Total Assets (Quarterly) : 33.07M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.07M |
| March 31, 2026 | 30.86M |
| December 31, 2025 | 15.07M |
| September 30, 2025 | 10.52M |
| June 30, 2025 | 13.47M |
| March 31, 2025 | 12.47M |
| December 31, 2024 | 14.86M |
| September 30, 2024 | 13.58M |
| June 30, 2024 | 5.127M |
| Date | Value |
|---|---|
| March 31, 2024 | 5.494M |
| December 31, 2023 | 3.491M |
| September 30, 2023 | 5.870M |
| June 30, 2023 | 5.227M |
| March 31, 2023 | 7.163M |
| December 31, 2022 | 11.41M |
| September 30, 2022 | 15.38M |
| June 30, 2022 | 13.80M |
| March 31, 2022 | 18.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.599M |
| Shareholders Equity (Quarterly) | 23.47M |
| Debt to Equity Ratio | 0.2681 |
| Current Ratio | 3.50 |
| Net Debt Paydown Yield | -0.32% |